NCT06168812View on ClinicalTrials.gov

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

December 5, 2026

Study Completion Date

December 5, 2026

Conditions
Pancreatic CancerPancreatic CarcinomaPancreatic Ductal AdenocarcinomaPancreatic Cancer MetastaticMetastatic Pancreatic CancerMetastatic Pancreatic Ductal Adenocarcinoma
Interventions
DRUG

Glipizide

The therapeutic intervention in this study involves the sulfonylurea glipizide in ER formulation.

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack

07920

RECRUITING

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

All Listed Sponsors
collaborator

University of California, Berkeley

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER